FSTL3 and invasive breast carcinoma: Actually, the present demonstration of variable FSTL3 distribution in invasive breast cancer, ranging from faint and scattered to strong and widespread, suggests that this protein might represent an endogenous mechanism of cell growth that is active in specific tumors and has the potential to be targeted therapeutically.